Fluorous tolerance of the estrogen receptor alpha as probed by 11-polyfluoroalkylestradiol derivatives

Steroids

Volumn 73, Issue 3, 2008, Pages 320-327

  Agouridas, Vangelis ^a   Blazejewski, Jean Claude ^a   Cleeren, Anny ^b   Laïos, Ioanna ^b   Leclercq, Guy ^b   Magnier, Emmanuel ^a  

^a UNIVERSITÉ DE VERSAILLES SAINT QUENTIN EN YVELINES   (France)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

Binding; Estradiol receptor alpha; Perfluoroalkyl steroid

Indexed keywords

11 POLYFLUOROALKYLESTRADIOL DERIVATIVE; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTROGEN RECEPTOR ALPHA; STEROID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; FLUORINATION; SYNTHESIS;

EID: 38649107048     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.11.002     Document Type: Article

References (51)

1. O'Hagan D., and Harper D.B. Fluorine-containing natural products. J Fluorine Chem 100 (1999) 127-133
2. Thayer A.M. Fabulous fluorine. Chem Eng News 84 (2006) 15-32
3. Bégué J.P., and Bonnet-Delpon D. Recent advances (1995-2005) in fluorinated pharmaceuticals based on natural products. J Fluorine Chem 127 (2006) 992-1012
4. Leo A., Hansch C., and Elkins D. Partition coefficients and their uses. Chem Rev 71 (1971) 525-616
5. Park B.K., Kitteringham N.R., and O'Neill P.M. Metabolism of fluorine-containing drugs. Ann Rev Pharmacol Toxicol 41 (2001) 443-470
6. Gerebtzoff G., Li-Blatter X., Fischer H., Frentzel A., and Seelig A. Halogenation of drugs enhances membrane binding and permeation. Chembiochem 5 (2004) 676-684
7. Gladysz J.A., Curran P., and Horváth I.T. Handbook of fluorous chemistry (2004), Wiley-VCH Verlag GmbH & Co. KgaA, Weinheim, Germany
8. Yoder N.C., Yüksel D., Dafik L., and Kumar K. Bioorthogonal noncovalent chemistry: fluorous phases in chemical biology. Curr Opin Chem Biol 10 (2006) 576-583
9. Krafft M.P., and Fluorocarbons. fluorinated amphiphiles in drug delivery and biomedical research. Adv Drug Delivery Rev 47 (2001) 209-228
10. Williams J.R., and Shea T.J. The synthesis of 3-substituted perfluoroalkyl steroids. Steroids 61 (1996) 50-57
11. Sharts C.M., Malik A.A., Easdon J.C., and Khawli L.A. Synthesis of perfluoroalkyl steroids as co-emulsifying agents for 1-bromoperfluorooctane and others perfluorocompounds. J Fluorine Chem 34 (1987) 365-383
12. Huang W.Y., Hu L.Q., and Ge W.Z. Synthesis of cholesterol and its analogs with fluorinated side-chains. J Fluorine Chem 43 (1989) 305-318
13. Carroll J.N., Pinkerton F.D., Su X., Gerst N., Wilson W.K., and Schroepfer Jr. J.G. Sterol synthesis. Synthesis of 3β-hydroxy-25,26,26,26,27,27,27-heptafluorocholest-5-en-7-one and its effects on HMG-CoA reductase activity in Chinese hamster ovary cells, on ACAT activity in rat jejunal microsomes, and serum cholesterol levels in rats. Chem Phys Lipids 94 (1998) 209-225 and references cited therein
14. Blazejewski J.C., Wilmshurst M.P., Popkin M.E., Wakselman C., Laurent G., Nonclercq D., et al. Synthesis, characterization and biological evaluation of 7α-perfluoroalkylestradiol derivatives. Bioorg Med Chem 11 (2003) 335-345
15. Agouridas V., Blazejewski J.C., Magnier E., and Popkin M.E. Synthesis of 11β-perfluorohexylestradiol. J Org Chem 70 (2005) 8907-8912
16. Tedesco R., Katzenellenbogen J.A., and Napolitano E. 7α,11β-Disubstituted estrogens: probes for the shape of the ligand binding pocket in the estrogen receptor. Bioorg Med Chem Lett 7 (1997) 2919-2924
17. Poupaert J.H., Lambert D.M., Vamecq J., and Abul-Hajj Y.J. Molecular modeling studies on 11β-aminoethoxyphenyl and 7α-aminoethoxyphenyl estradiols. Evidence suggesting a common hydrophobic pocket in estrogen receptor. Bioorg Med Chem Lett 5 (1995) 839-842
18. Anstead G.M., Carlson K.E., and Katzenellenbogen J.A. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62 (1997) 268-303
19. Fang H., Tong W., Shi L.M., Blair R., Perkins R., Branham W., et al. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol 14 (2001) 280-294
20. Lobaccaro C., Pons J.F., Duchesne M.J., Auzou G., Pons M., Nique F., et al. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11β-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties. J Med Chem 40 (1997) 2217-2227
21. Pike A.C.W., Brzozowski A.M., Walton J., Hubbard R.E., Thorsell A.G., Li Y.L., et al. Structural insights into the mode of action of a pure antiestrogen. Structure 9 (2001) 145-153
22. Jordan V.C. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J Med Chem 46 (2003) 1081-1111
23. Zhang J.X., Labaree D.C., and Hochberg R.B. Nonpolar and short side chain groups at C-11β of estradiol result in antiestrogens. J Med Chem 48 (2005) 1428-1447
24. Jiang X.R., Sowell J.W., and Zhu T.B. Synthesis of 7α-substituted derivatives of 17β-estradiol. Steroids 71 (2006) 334-342
25. Robertson J.F.R., Come S.E., Jones S.E., Beex L., Kaufmann M., Makris A., et al. Endocrine treatment options for advanced breast cancer-the role of fulvestrant. Eur J Cancer 41 (2005) 346-356
26. MacGregor J.I., and Jordan V.C. Basic guide to the mechanisms of antiestrogen action. Pharm Rev 50 (1998) 151-196
27. Hanson R.N., Tongcharoensirikul P., Dilis R., Hughes A., and DeSombre E.R. (17α,20E)-11β-Methoxy-21-(trifluoromethylphenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17β-diols as ER-hormone binding domain ligands: effect of the methoxy group on receptor binding and uterotrophic growth. J Med Chem 50 (2007) 472-479
28. Isanbor C., and O'Hagan D. Fluorine in medicinal chemistry: a review of anti-cancer agents. J Fluorine Chem 127 (2006) 303-319
29. Maaroufi Y., and Leclercq G. Importance of A/B and C domains of the estrogen receptor for its adsorption to hydroxylapatite. J Steroid Biochem Mol Biol 48 (1994) 155-163
30. Akanni A.O., and Marples B.A. Improved preparation of 3β, 17β-diacetoxyoestra-1,3,5(10)-triene-6-one. Syn Commun 14 (1984) 713-715
31. Umemoto T., Kuriu Y., Shuyama H., Miyano O., and Nakayama S.I. Syntheses and properties of (perfluoroalkyl)phenyliodonium triflates (FITS reagents) and their analogues. J Fluorine Chem 31 (1986) 37-56
32. Labaree D.C., Zhang J.X., Harris H.A., O'Connor C., Reynolds T.Y., and Hochberg R.B. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens. J Med Chem 46 (2003) 1886-1904
33. Tedesco R., Fiaschi R., and Napolitano E. Novel stereoselective synthesis of 11β-carbon-substituted estradiol derivatives. J Org Chem 60 (1995) 5316-5318
34. Burton D.J., and Yang Z.Y. Fluorinated organometallics: perfluoroalkyl and functionalized perfluoroalkyl organometallic reagents in organic synthesis. Tetrahedron 48 (1992) 189-275
35. Creary X. Electronegatively substituted carbocations. Chem Rev 91 (1991) 1625-1677
36. van Alem K., Belder G., Lodder G., and Zuilhof H. Photochemical generation of highly destabilized vinyl cations: the effects of α and β-trifluoromethyl versus α and β-methyl substituents. J Org Chem 70 (2005) 179-190 and references therein
37. Lecomte V., Stephan E., Rager M.N., and Jaouen G. Versatile use of hindered oxalates for the stereoselective preparation of novel 11-modified androst-5-ene derivatives. J Org Chem 69 (2004) 3216-3219
38. Buckmelter A.J., Kim A.I., and Rychnovsky D.R. Conformational memory in enantioselective radical reductions and a new radical clock reaction. J Am Chem Soc 122 (2000) 9386-9390
39. Gao H., Katzenellenbogen J.A., Garg R., Hansch C., and Comparative. QSAR analysis of estrogen receptor ligands. Chem Rev 99 (1999) 723-744
40. Zhu B.T., Han G.Z., Shim J.Y., Wen Y., and Jiang X.R. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor α and β subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 147 (2006) 4132-4150
41. Gao J., Qiao S., and Whitesides G.M. Increasing binding constants of ligands to carbonic anhydrase by using "greasy tails". J Med Chem 38 (1995) 2292-2301
42. Leo A., Hansch C., and Jow P.Y.C. Dependence of hydrophobicity of apolar molecules on their molecular volume. J Med Chem 19 (1976) 611-615
43. Yokozeki A., and Bauer S.H. The geometric and dynamic structures of fluorocarbons and related compounds. Top Curr Chem 53 (1975) 71-119
44. Schlosser M., and Michel D. About the "physiological size" of fluorine substituents: comparison of sensorially active compounds with fluorine and methyl substituted analogues. Tetrahedron 52 (1996) 99-108
45. Carcenac Y., Tordeux M., Wakselman C., and Diter P. Experimental determination of the conformational free energies (A values) of fluorinated substituents in cyclohexane by dynamic 19F NMR spectroscopy. Part 2: Extension to fluoromethyl, difluoromethyl, pentafluoroethyl, trifluoromethylthio and trifluoromethoxy groups. New J Chem 1 (2006) 447-457
46. 19F NMR to interpret the structural properties of perfluorocarboxylate acids: a possible correlation with their environmental disposition. J Phys Chem A 108 (2004) 10099-10106
47. Monde K., Miura N., Hashimoto M., Taniguchi T., and Inabe T. Conformational analysis of chiral helical perfluoroalkyl chains by VCD. J Am Chem Soc 128 (2006) 6000-6001
48. Biffinger J.C., Kim H.W., and DiMagno S.G. The polar hydrophobicity of fluorinated compounds. Chembiochem 5 (2004) 622-627
49. Ahamindra Jain A., Whitesides G.M., Alexander R.S., and Christianson D.W. Identification of two hydrophobic patches in the active-site cavity of human carbonic anhydrase II by solution-phase and solid-state studies and their use in the development of tight-binding inhibitors. J Med Chem 37 (1994) 2100-2106
50. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engström O., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 (1997) 753-758
51. Celik L., Dalsgaard Lund J.D., and Schiøtt B. Conformational dynamics of the estrogen receptor R: molecular dynamics simulations of the influence of binding site structure on protein dynamics. Biochemistry 46 (2007) 1743-1758